Edition:
United Kingdom

Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Capital Market

1.28USD
6:33pm BST
Change (% chg)

$0.02 (+1.59%)
Prev Close
$1.26
Open
$1.27
Day's High
$1.30
Day's Low
$1.26
Volume
44,932
Avg. Vol
33,540
52-wk High
$3.69
52-wk Low
$1.03

Chart for

About

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including... (more)

Overall

Beta: 1.99
Market Cap(Mil.): $30.56
Shares Outstanding(Mil.): 11.40
Dividend: --
Yield (%): --

Financials

  VICL.OQ Industry Sector
P/E (TTM): -- 85.69 32.76
EPS (TTM): -1.04 -- --
ROI: -27.79 1.78 14.61
ROE: -27.82 3.28 16.33

BRIEF-Vical Reports Q1 Loss Per Share $0.29

* VICAL REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATIONAL RESULTS

03 May 2018

BRIEF-Vical Reports Q4 Loss Per Share Of $0.21

* VICAL REPORTS FOURTH QUARTER 2017 FINANCIAL AND OPERATIONAL RESULTS

15 Mar 2018

Competitors

  Price Chg
Sanofi SA (SASY.PA) €74.37 +0.94
Novartis AG (NOVN.S) CHF83.08 +0.20
GlaxoSmithKline plc (GSK.L) 1,612.80 -6.60
AstraZeneca plc (AZN.L) 5,956.00 -23.00
Merck & Co., Inc. (MRK.N) $69.33 -0.84
Pfizer Inc. (PFE.N) $42.24 -0.09
Roche Holding Ltd. (ROG.S) CHF242.90 +0.90
Roche Holding Ltd. (RO.S) CHF245.80 0.00
Genocea Biosciences Inc (GNCA.OQ) $0.64 +0.02
Agenus Inc (AGEN.OQ) $1.85 +0.26

Earnings vs. Estimates